Standout Papers

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis 2014 2026 2018 2022 2.5k
  1. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (2014)
    Talmadge E. King, Williamson Z. Bradford et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 10 from Science/Nature 84 standout
Sub-graph 1 of 22

Citing Papers

Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis
2024 StandoutNature
Interstitial Lung Disease
2024 Standout
3 intermediate papers

Works of Ian Glaspole being referenced

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
2015
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2014 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Ian Glaspole 5295 1724 645 115 6.1k
Mary E. Strek 4209 1786 1245 112 5.2k
Antoni Xaubet 3338 1539 951 168 5.4k
Shosaku Abe 3394 1509 834 203 5.6k
Kevin O. Leslie 3699 1083 840 144 5.6k
K. Andrássy 4941 1624 572 152 7.3k
Sonoko Nagai 4138 1912 1346 111 5.6k
Wim Wuyts 3898 1549 621 168 5.0k
Olof Selroos 4125 4396 456 134 5.3k
Paolo Spagnolo 4458 2114 881 168 5.8k
Imre Noth 5074 1901 914 123 5.8k

All Works

Loading papers...

Rankless by CCL
2026